ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, J. I.
Right arrow Articles by Phillips, T. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, J. I., Jr
Right arrow Articles by Phillips, T. W.

The Annals of Thoracic Surgery, Vol 50, 190-195, Copyright © 1990 by The Society of Thoracic Surgeons


ARTICLES

Neodymium:YAG laser and brachytherapy in the management of inoperable bronchogenic carcinoma

JI Miller Jr and TW Phillips
Department of Cardio-Thoracic Surgery, Woodruff Health Sciences Center, Emory University School of Medicine, Atlanta, Georgia.

Neodymium:yttrium-aluminum garnet (Nd:YAG) laser therapy and endobronchial brachytherapy are useful modalities in the palliation of inoperable bronchogenic carcinoma. From 1983 to 1989, 218 patients underwent a total of 371 procedures involving endobronchial brachytherapy, Nd:YAG laser therapy, or both. Group 1 consisted of 130 patients who received Nd:YAG laser therapy. Group 2 consisted of 67 patients who had endobronchial brachytherapy only. Group 3 comprised 21 patients who underwent combined endobronchial brachytherapy and Nd:YAG laser therapy. All patients had received or were receiving concurrent radiotherapy. Three late deaths occurred in group 1, and 1 death occurred in group 2. More than 80% of patients achieved a good to excellent result. When applicable, we now use combined Nd:YAG laser therapy and endobronchial brachytherapy as part of the initial management of inoperable non-small cell bronchogenic carcinoma. A detailed analysis of these patients is given.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
M. E. Halkos, K. D. Godette, E. C. Lawrence, and J. I. Miller Jr
High dose rate brachytherapy in the management of lung transplant airway stenosis
Ann. Thorac. Surg., August 1, 2003; 76(2): 381 - 384.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. D. Morris, J. M. Budde, K. D. Godette, T. L. Kerwin, and J. I. Miller Jr
Palliative management of malignant airway obstruction
Ann. Thorac. Surg., December 1, 2002; 74(6): 1928 - 1933.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
L. M. Seijo and D. H. Sterman
Interventional Pulmonology
N. Engl. J. Med., March 8, 2001; 344(10): 740 - 749.
[Full Text] [PDF]


Home page
The OncologistHome page
C. G. Compeau and S. Keshavjee
Management of Tracheal Neoplasms
Oncologist, December 1, 1996; 1(6): 347 - 353.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1990 by The Society of Thoracic Surgeons.